{"id":920555,"date":"2025-12-17T08:31:59","date_gmt":"2025-12-17T13:31:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/"},"modified":"2025-12-17T08:31:59","modified_gmt":"2025-12-17T13:31:59","slug":"e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/","title":{"rendered":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Dec.  17, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_hxUM_jepUfnDLXTqf7A2k23SSY_y3J6Idl4_7dYJYvaSgGYhxzSLtBQy9R9MtxHDwBHJsOOMgxD8Dkw0UIt4w==\" rel=\"nofollow\" target=\"_blank\">E.F. Hutton<\/a> is proud to have served as an Exclusive M&amp;A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS)<em>\u00a0<\/em>and Mindwave Innovations Inc. The merger brings together a biotech development platform with an AI-powered digital treasury infrastructure supported by a $100 million PIPE commitment, for which E.F. Hutton acted as Placement Agent. E.F. Hutton\u2019s involvement underscores its commitment to advancing the combined company\u2019s strategic growth across late-stage biotech development and institutional Digital Asset Treasury Solutions.<\/p>\n<p>E.F. Hutton worked closely with both companies to shape the transaction framework, coordinate investor participation, and guide the capital raise through a complex diligence and negotiation process. The merger gives the combined business access to a significant financing pathway while integrating MindWave\u2019s AI-driven treasury engine, which is designed to optimize how the company manages and grows its capital over time. Apimeds\u2019 biotech late-stage, non-opioid pain-management biologic portfolio and MindWave\u2019s digital AI-driven Bitcoin treasury, digital asset yield generation, and $NILA-powered ecosystem together establish a platform designed for long-term scalability. The E.F. Hutton team helped design a capital strategy that matches that ambition.<\/p>\n<p>\u201cWe are delighted to have advised Apimeds and MindWave on this compelling merger \u2013 a deal that captures the future of biotech innovation merged with AI-based financial optimization,\u201d said Joseph Rallo, Chief Executive Officer of EF Hutton. \u201cThis transaction underscores EF Hutton\u2019s ability to deliver bespoke capital markets solutions and strategic advisory services that drive value creation for emerging-growth companies across sectors.\u201d<\/p>\n<p>With the new PIPE facility and MindWave\u2019s technology integrated into its operations, the combined entity is positioned to accelerate its development pipeline while gaining a more efficient system for capital deployment. E.F. Hutton\u2019s role included advising on transaction terms, working alongside both management teams on strategic alignment, and orchestrating key elements of the financing execution.<\/p>\n<p>This engagement continues to expand E.F. Hutton\u2019s presence in structuring complex capital solutions, cross-sector mergers, and innovative financing models that support companies navigating pivotal stages of growth.<\/p>\n<p>Contact Information:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6UFsSG55CQuHrtqzrMiJz1lPH3U0PwCYaT1zx5fmyN_toBZsWo_yK1srCw4JCTp-VidlxvmyDm3HLECs0CExpJFAXatTJFPTavP7bFwq4hI=\" rel=\"nofollow\" target=\"_blank\">info@efhutton.com<\/a><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v9-XvJXbrE39IvCC7k-HjGDWqvf0TlGnXtK5ML86JvTkcIdZE8WIJNVHZC69SN1r1jiq0FDEXHEqxu1l8fW2AKaM-dG31Hr7mpxh7AFnhpk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/efhutton.com<\/a><br \/>\n        <br \/>(212) 970-3700<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDVmYjNhY2EtMGUxNC00NjdkLTkyMjktNDA5YWMyZmUwYjAxLTUwMDE1NjIzMS0yMDI1LTEyLTE3LWVu\/tiny\/EF-Hutton.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) &#8212; E.F. Hutton is proud to have served as an Exclusive M&amp;A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS)\u00a0and Mindwave Innovations Inc. The merger brings together a biotech development platform with an AI-powered digital treasury infrastructure supported by a $100 million PIPE commitment, for which E.F. Hutton acted as Placement Agent. E.F. Hutton\u2019s involvement underscores its commitment to advancing the combined company\u2019s strategic growth across late-stage biotech development and institutional Digital Asset Treasury Solutions. E.F. Hutton worked closely with both companies to shape the transaction framework, coordinate investor participation, and guide the capital raise through a complex diligence and negotiation process. The merger gives the combined &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-920555","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) &#8212; E.F. Hutton is proud to have served as an Exclusive M&amp;A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS)\u00a0and Mindwave Innovations Inc. The merger brings together a biotech development platform with an AI-powered digital treasury infrastructure supported by a $100 million PIPE commitment, for which E.F. Hutton acted as Placement Agent. E.F. Hutton\u2019s involvement underscores its commitment to advancing the combined company\u2019s strategic growth across late-stage biotech development and institutional Digital Asset Treasury Solutions. E.F. Hutton worked closely with both companies to shape the transaction framework, coordinate investor participation, and guide the capital raise through a complex diligence and negotiation process. The merger gives the combined &hellip; Continue reading &quot;E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-17T13:31:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation\",\"datePublished\":\"2025-12-17T13:31:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/\"},\"wordCount\":374,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/\",\"name\":\"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\",\"datePublished\":\"2025-12-17T13:31:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/","og_locale":"en_US","og_type":"article","og_title":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk","og_description":"NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) &#8212; E.F. Hutton is proud to have served as an Exclusive M&amp;A Advisor in the recently completed merger between Apimeds Pharmaceuticals US Inc. (NYSE American: APUS)\u00a0and Mindwave Innovations Inc. The merger brings together a biotech development platform with an AI-powered digital treasury infrastructure supported by a $100 million PIPE commitment, for which E.F. Hutton acted as Placement Agent. E.F. Hutton\u2019s involvement underscores its commitment to advancing the combined company\u2019s strategic growth across late-stage biotech development and institutional Digital Asset Treasury Solutions. E.F. Hutton worked closely with both companies to shape the transaction framework, coordinate investor participation, and guide the capital raise through a complex diligence and negotiation process. The merger gives the combined &hellip; Continue reading \"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-17T13:31:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation","datePublished":"2025-12-17T13:31:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/"},"wordCount":374,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/","name":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==","datePublished":"2025-12-17T13:31:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYwMzQyNCM3MzI1Mzk1IzUwMDE1NjIzMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/e-f-hutton-advises-on-strategic-merger-between-apimeds-and-mindwave-aligning-biotech-growth-with-ai-enabled-financial-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=920555"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/920555\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=920555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=920555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=920555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}